Lisata Therapeutics, Inc.
LSTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000320017
No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 38 institutions reported holding it in 13F filings for Q3 2026, worth $7.55M in total; no superinvestor holds it.
13F holders, Q3 2026
Institutional positions in Lisata Therapeutics, Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +7 vs. Q2 2026
- Shares held
- 5.25M
- +4.04M (+334.1%) vs. Q2 2026
- Total value
- $7.55M
- +$3.45M (+83.9%) vs. Q2 2026
- New holders
- 14
- 4 more added
- Sold out
- 7
- 7 more reduced
1 institution that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LSTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q3 2026 | 38 | $7.55M |
| Q2 2026 | 32 | $4.11M |
| Q1 2026 | 34 | $7.06M |
| Q4 2025 | 25 | $1.36M |
| Q3 2025 | 21 | $1.93M |
| Q2 2025 | 20 | $2.26M |
| Q1 2025 | 22 | $1.84M |
| Q4 2024 | 21 | $2.33M |
| Q3 2024 | 20 | $2.30M |
| Q2 2024 | 22 | $2.61M |
| Q1 2024 | 21 | $2.30M |
| Q4 2023 | 22 | $2.03M |
| Q3 2023 | 21 | $1.46M |
| Q2 2023 | 22 | $2.51M |
| Q1 2023 | 21 | $2.08M |
| Q4 2022 | 24 | $1.83M |
| Q3 2022 | 22 | $2.18M |
| Q2 2022 | 36 | $5.00M |
| Q1 2022 | 34 | $6.13M |
| Q4 2021 | 36 | $7.33M |
| Q3 2021 | 34 | $9.41M |
| Q2 2021 | 29 | $10.1M |
| Q1 2021 | 33 | $12.9M |
Institutions, Q3 2026
Shares, value and share of portfolio for each institution holding Lisata Therapeutics, Inc.; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 2,487,646 | $3.58M | 0.01% | +2,487,646 | New |
| TRV GP V, LLC | 455,192 | $655.5K | 0.14% | +455,192 | New |
| Seven Fleet Capital Management LP | 371,411 | $534.8K | 0.10% | +371,411 | New |
| FCPM III Services B.V. | 297,478 | $428.4K | 0.04% | +297,478 | New |
| Vanguard Capital Management LLC | 278,837 | $401.5K | 0.00% | 00.0% | Unchanged |
| Falcon Edge Capital, LP | 183,323 | $264.0K | 0.01% | +183,323 | New |
| Sofinnova Investments, Inc. | 156,460 | $225.3K | 0.01% | +156,460 | New |
| venBio Partners LLC | 156,460 | $225.3K | 0.05% | +156,460 | New |
| Yakira Capital Management, Inc. | 135,520 | $195.1K | 0.05% | −3,041−2.2% | Reduced |
| Nantahala Capital Management, LLC | 101,221 | $145.8K | 0.01% | +101,221 | New |
| Citadel Advisors LLC | 76,275 | $109.8K | 0.00% | +60,734+390.8% | Added |
| Geode Capital Management, LLC | 72,632 | $104.6K | 0.00% | 00.0% | Unchanged |
| Deltec Asset Management LLC | 63,197 | $91.0K | 0.01% | −20,000−24.0% | Reduced |
| BlackRock, Inc. | 54,857 | $79.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 48,964 | $70.5K | 0.00% | 00.0% | Unchanged |
| TRV GP VI, LLC | 48,446 | $69.8K | 0.03% | +48,446 | New |
| CSS LLC | 41,222 | $59.4K | 0.00% | −69,200−62.7% | Reduced |
| GTS Securities LLC | 35,500 | $51.1K | 0.00% | +5,300+17.5% | Added |
| Virtu Financial LLC | 34,435 | $50.0K | 0.00% | −24,347−41.4% | Reduced |
| Jane Street Group, LLC | 28,142 | $40.5K | 0.00% | +9,401+50.2% | Added |
| State Street Corp | 25,348 | $36.5K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 18,083 | $26.0K | 0.00% | +18,083 | New |
| Northern Trust Corp | 14,465 | $20.8K | 0.00% | −1,069−6.9% | Reduced |
| UBS Group AG | 13,579 | $19.6K | 0.00% | +13,579 | New |
| FNY Investment Advisers, LLC | 13,000 | $18.0K | 0.00% | +13,000 | New |
| Cerity Partners LLC | 12,183 | $17.5K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 10,353 | $14.9K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 10,042 | $14.5K | 0.00% | 00.0% | Unchanged |
| Vanguard Global Advisers, LLC | 1,033 | $1.49K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 250 | $360 | 0.00% | +50+25.0% | Added |
| Morgan Stanley | 75 | $108 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 8 | $12 | 0.00% | +8 | New |
| SBI Securities Co., Ltd. | 7 | $10 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 4 | $6 | 0.00% | −86−95.6% | Reduced |
| Cheviot Value Management, LLC | 3 | $4 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 2 | $3 | 0.00% | −68−97.1% | Reduced |
| Fortitude Family Office, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $1 | 0.00% | +1 | New |
| Deeter Investments LLP | 0 | $0 | 0.00% | −118,871−100.0% | Sold out |
| Rangeley Capital, LLC | 0 | $0 | 0.00% | −81,000−100.0% | Sold out |
| JBF Capital, Inc. | 0 | $0 | 0.00% | −14,347−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Founders Capital Management | 0 | $0 | 0.00% | −1,667−100.0% | Sold out |
| Connective Capital Management, LLC | 0 | $0 | 0.00% | −1,016−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −726−100.0% | Sold out |
| Royal Bank of Canada | – | – | – | – | Not filed |